Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
311 DKK | -2.81% | +2.98% | +148.80% |
Apr. 17 | Gubra Unveils UCN2 as Novel Anti-Obesity Drug Candidate for Healthy Weight Loss | CI |
Mar. 29 | Certain Shares of Gubra A/S are subject to a Lock-Up Agreement Ending on 29-MAR-2024. | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GUBRA A/S | Bio Therapeutic Drugs | -2.81% | +2.98% | +148.80% | +214.52% | - | 737M |
Technical Rankings Surperformance
- Stock Market
- Equities
- GUBRA Stock
- Charts Gubra A/S
- Comparison Chart